C1OO34 Stock Overview
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
The Cooper Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$46.80 |
| 52 Week High | US$48.51 |
| 52 Week Low | US$39.91 |
| Beta | 0.95 |
| 1 Month Change | 0% |
| 3 Month Change | -3.50% |
| 1 Year Change | -3.52% |
| 3 Year Change | -15.68% |
| 5 Year Change | n/a |
| Change since IPO | 25.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| C1OO34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 0.7% |
| 1Y | -3.5% | -1.8% | 14.9% |
Return vs Industry: C1OO34 exceeded the BR Medical Equipment industry which returned -5% over the past year.
Return vs Market: C1OO34 underperformed the BR Market which returned 13.1% over the past year.
Price Volatility
| C1OO34 volatility | |
|---|---|
| C1OO34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 8.7% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: C1OO34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine C1OO34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies, Inc. Fundamentals Summary
| C1OO34 fundamental statistics | |
|---|---|
| Market cap | R$93.59b |
| Earnings (TTM) | R$1.51b |
| Revenue (TTM) | R$19.09b |
61.8x
P/E Ratio4.9x
P/S RatioIs C1OO34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| C1OO34 income statement (TTM) | |
|---|---|
| Revenue | US$3.67b |
| Cost of Revenue | US$1.24b |
| Gross Profit | US$2.42b |
| Other Expenses | US$2.13b |
| Earnings | US$290.80m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 1.46 |
| Gross Margin | 66.09% |
| Net Profit Margin | 7.93% |
| Debt/Equity Ratio | 36.0% |
How did C1OO34 perform over the long term?
See historical performance and comparison